Melatonin prevents the development of the metabolic syndrome in male rats exposed to different light/dark regimens (Q44926781)

7 December 2017

title

Melatonin prevents the development of the metabolic syndrome in male rats exposed to different light/dark regimens (English)

1 reference

7 December 2017

0 references

1 reference

Irina Vinogradova

1

1 reference

7 December 2017

Vladimir Anisimov

series ordinal

2

1 reference

7 December 2017

publication date

20 June 2013

1 reference

7 December 2017

1 reference

7 December 2017

volume

14

1 reference

7 December 2017

issue

4

1 reference

7 December 2017

page(s)

401-409

1 reference

Impaired nocturnal synthesis of melatonin in patients with cardiac syndrome X.

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Insulin/IGF-1 signaling pathway driving aging and cancer as a target for pharmacological intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

The role of pineal gland in breast cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Cancer in rodents: does it tell us about cancer in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Melatonin: Characteristics, Concerns, and Prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Metabolic syndrome in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Pricing medicines: theory and practice, challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Lack of melatonin effects on insulin action in normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Photons, clocks, and consciousness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Influence of melatonin administration on glucose tolerance and insulin sensitivity of postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Effects of pinealectomy and exogenous melatonin on serum leptin levels in male rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

In vivo and in situ action of melatonin on insulin secretion and some metabolic implications in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Examination of the melatonin hypothesis in women exposed at night to EMF or bright light

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Shiftwork and metabolic risk factors of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

A conserved regulatory system for aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Health disorders of shift workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Shiftwork and cardiovascular disease: review of disease mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

A work in progress: the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Effects of continuous light and melatonin treatment on energy metabolism of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Long-term melatonin administration reduces hyperinsulinemia and improves the altered fatty-acid compositions in type 2 diabetic rats via the restoration of Delta-5 desaturase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Melatonin inhibits insulin secretion and decreases PKA levels without interfering with glucose metabolism in rat pancreatic islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Melatonin: a principal neuroimmunoregulatory and anti-stress hormone: its anti-aging effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Coordination of circadian timing in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Shift work, shift change, and risk of death from heart disease at work

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Circadian disruption and breast cancer: from melatonin to clock genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Artificial lighting in the industrialized world: circadian disruption and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Obesity and metabolic syndrome in circadian Clock mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10522-013-9437-4

10.1007/S10522-013-9437-4

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference